Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Other Non-Current Liabilities (2021 - 2025)

Oncology Institute (TOI) has disclosed Other Non-Current Liabilities for 5 consecutive years, with $3000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities fell 99.42% year-over-year to $3000.0, compared with a TTM value of $3000.0 through Sep 2025, down 99.42%, and an annual FY2024 reading of $385000.0, up 5.48% over the prior year.
  • Other Non-Current Liabilities was $3000.0 for Q3 2025 at Oncology Institute, down from $10000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $20.6 million in Q1 2022 and bottomed at $3000.0 in Q3 2025.
  • Average Other Non-Current Liabilities over 5 years is $4.1 million, with a median of $533500.0 recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities skyrocketed 165.1% in 2022, then plummeted 99.42% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $9.3 million in 2021, then tumbled by 57.22% to $4.0 million in 2022, then tumbled by 90.78% to $365000.0 in 2023, then increased by 5.48% to $385000.0 in 2024, then tumbled by 99.22% to $3000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for TOI at $3000.0 in Q3 2025, $10000.0 in Q2 2025, and $117000.0 in Q1 2025.